{"schemaVersion":"peptidescanner-clinical-trials-history-object/v1","objectId":"clinical-trials-history:NCT04064411","recordId":"NCT04064411","peptideSlug":"abaloparatide","publishedAt":"2026-08-23","sourceObservedAt":"2026-08-23T23:32:33.000Z","sourceObservationSha256":"6ae8058d20bbb511d9250d19ac0bd3475945bb56f0057fdb437648218b72606e","urls":{"human":"https://peptidescanner.com/stories/clinicaltrials-gov-nct04064411-abaloparatide/","json":"https://peptidescanner.com/clinical-trials-history/v1/trials/nct04064411.json","markdown":"https://peptidescanner.com/clinical-trials-history/v1/trials/nct04064411.md"},"reportingBoundary":"ClinicalTrials.gov lists this public record-history version and identifies its submitted date and the source modules marked as changed. PeptideScanner does not infer what changed inside a module, why it changed, whether the change is material, whether the study is trustworthy, or whether an intervention is safe or effective.","versions":[{"changedModules":[],"historyVersion":1,"lastUpdateSubmitQcDate":"2019-08-19","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"RECRUITING","peptideSlug":"abaloparatide","submittedDate":"2019-08-19","publishedAt":"2026-08-23","recordId":"NCT04064411","recordSha256":"94cbf2b549e3421c4484ee0aa6d4ea962b1e2998870164dcac547e1142e68f75","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT04064411?a=1&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["Contacts/Locations","Sponsor/Collaborators","Study Identification","Study Status"],"historyVersion":2,"lastUpdateSubmitQcDate":"2019-10-10","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"RECRUITING","peptideSlug":"abaloparatide","submittedDate":"2019-10-10","publishedAt":"2026-08-23","recordId":"NCT04064411","recordSha256":"3a09d2b3402ff5b6ba69e97a828df8a6840a922ca98c2e74ee5cde0b585578c8","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT04064411?a=2&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["Contacts/Locations","Study Status"],"historyVersion":3,"lastUpdateSubmitQcDate":"2019-10-16","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"RECRUITING","peptideSlug":"abaloparatide","submittedDate":"2019-10-16","publishedAt":"2026-08-23","recordId":"NCT04064411","recordSha256":"c65f1a7cff2655ecffadd6ccdd89b689ed585e3a542d00ab6537f236650bc6c7","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT04064411?a=3&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["Contacts/Locations","Study Status"],"historyVersion":4,"lastUpdateSubmitQcDate":"2019-12-03","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"RECRUITING","peptideSlug":"abaloparatide","submittedDate":"2019-12-03","publishedAt":"2026-08-23","recordId":"NCT04064411","recordSha256":"d7d96fafffc1893d8029e3584700286ac858a4eef22c2da508e8c83e72457d6d","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT04064411?a=4&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["Contacts/Locations","Study Status"],"historyVersion":5,"lastUpdateSubmitQcDate":"2020-01-16","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"RECRUITING","peptideSlug":"abaloparatide","submittedDate":"2020-01-16","publishedAt":"2026-08-23","recordId":"NCT04064411","recordSha256":"3953d7443f990e8dcab238da191cd0cd63b46c2f4891c85bd9b5d96fccaa8558","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT04064411?a=5&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["Contacts/Locations","Study Status"],"historyVersion":6,"lastUpdateSubmitQcDate":"2020-03-18","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"RECRUITING","peptideSlug":"abaloparatide","submittedDate":"2020-03-18","publishedAt":"2026-08-23","recordId":"NCT04064411","recordSha256":"618782b1d97c3ac2c863bc9218d5ce5ee3c554cf6f2ba8f4422b896fd10cb3c2","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT04064411?a=6&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["Contacts/Locations","Study Status"],"historyVersion":7,"lastUpdateSubmitQcDate":"2020-06-09","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"RECRUITING","peptideSlug":"abaloparatide","submittedDate":"2020-06-09","publishedAt":"2026-08-23","recordId":"NCT04064411","recordSha256":"ddbebf950ac7b3479bbbf60d2ce3c834a813dd7ea413f4217963c95a8e2867c4","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT04064411?a=7&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["Contacts/Locations","Study Status"],"historyVersion":8,"lastUpdateSubmitQcDate":"2020-09-10","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"ACTIVE_NOT_RECRUITING","peptideSlug":"abaloparatide","submittedDate":"2020-09-10","publishedAt":"2026-08-23","recordId":"NCT04064411","recordSha256":"80644db95d0e9444f767df8e0517a9424c476337d68086a5e1f2ea3aad9c4551","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT04064411?a=8&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["Study Status"],"historyVersion":9,"lastUpdateSubmitQcDate":"2020-12-03","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"ACTIVE_NOT_RECRUITING","peptideSlug":"abaloparatide","submittedDate":"2020-12-03","publishedAt":"2026-08-23","recordId":"NCT04064411","recordSha256":"cf0a7ae08f01d00390276acac58678d60230fd1635bc49c87c9fa8e93829d887","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT04064411?a=9&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["Contacts/Locations","Study Status"],"historyVersion":10,"lastUpdateSubmitQcDate":"2021-04-12","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"ACTIVE_NOT_RECRUITING","peptideSlug":"abaloparatide","submittedDate":"2021-04-12","publishedAt":"2026-08-23","recordId":"NCT04064411","recordSha256":"7a1acbacccb750b5a993d4c7d7de9d3502c761f2aef03d0ebf10ecdb04875272","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT04064411?a=10&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["Study Design","Study Status"],"historyVersion":11,"lastUpdateSubmitQcDate":"2022-01-05","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"COMPLETED","peptideSlug":"abaloparatide","submittedDate":"2022-01-05","publishedAt":"2026-08-23","recordId":"NCT04064411","recordSha256":"21cb61ee3b821bb4c20f73c26ee76f4d9fbf40b20e6dcc44537039c4070a200d","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT04064411?a=11&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["Baseline Characteristics","Study Status"],"historyVersion":14,"lastUpdateSubmitQcDate":"2023-02-14","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"COMPLETED","peptideSlug":"abaloparatide","submittedDate":"2023-02-14","publishedAt":"2026-08-23","recordId":"NCT04064411","recordSha256":"00035753727773e7306c74c3065c838d90bcd32efdc54cbde8c410cb8ad28a86","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT04064411?a=14&tab=history","studyType":"INTERVENTIONAL"}],"integrity":{"algorithm":"sha256","contentSha256":"317b882bcb6483a24f767ea0e0738a58823cd00947d47fb4b2d6fcff61d743d5"}}